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Abstract
Objective It has been suspected that cobalt is toxic to the heart. It can cause cardiotoxicity in heavily exposed humans and 
in experimental systems. The issue of interest for this study is whether cobalt also affects the myocardium at occupational 
exposure levels.
Methods To study the effect of occupational cobalt exposure on the heart, we conducted a follow-up of workers at a cobalt 
production plant. The workers’ hearts had been examined by echocardiography in 1999–2000. Altogether 93 exposed and 49 
non-exposed workers examined in 1999–2000 were re-examined in 2006. Occupational history and health data were collected 
with a questionnaire. Blood pressure was measured, and electrocardiography (ECG), laboratory tests, Holter registration, 
and echocardiography were conducted for all participants. Analysis of covariance (ANCOVA) was used to analyse the data.
Results No differences were found between the exposed and unexposed groups for any of the echocardiographic parameters 
in 2006. There were no differences in the laboratory values, the ECG parameters, or the results of the Holter registration of 
the exposed and unexposed workers.
Conclusions Although the previous results in 2000 suggested an association between cumulative exposure to cobalt and 
echocardiographic findings, the results of this new cross-sectional study with a tissue Doppler 6 years later did not confirm 
the association in the present cohort. If cobalt exposure affects heart muscle functions at this exposure level, the effects are 
smaller than those caused by physiological changes due to ageing, medication, and traditional cardiovascular risk factors, 
such as elevated blood pressure.
Keywords Cardiomyopathy · Cobalt exposure · Work-related heart symptoms and disease · Echocardiography
Introduction
The toxic potential of cobalt and related health risks have 
been investigated thoroughly in animal and human toxicity 
studies. Systemic toxic reactions may arise when Co ions 
enter the blood and lymphatic circulation and subsequently 
disseminate to different organs. In vitro experiments have 
demonstrated that ionized cobalt (Co2 +) is the primary 
toxic form for systemic toxicity (Leyssens et al. 2017). Var-
ious pathogenetic mechanisms related to possible cardiac 
effects have been suspected in hard-metal workers. Accord-
ing to some authors, the most likely effect is the inhibition 
of cellular respiration due to the inhibition of mitochondrial 
dehydrogenase (Seghizzi et al. 1994). Systemic Co toxicity 
manifests as a clinical syndrome with a variable presentation 
of neurological, cardiovascular, sensitizing, and endocrine 
symptoms, depending on the systemic Co levels (blood/
urine).
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Single cardiomyopathy cases have been reported among 
persons exposed occupationally to cobalt (Kennedy et al. 
1981; Jarvis et al. 1992). In two small groups of hard-metal 
workers studied earlier, a weak but still significant inverse 
correlation was found between exposure time and the left 
ventricular ejection fraction as measured by radionuclide 
ventriculography (Horowitz et al. 1988).
A significantly lower left ventricular ejection fraction 
during both rest and exercise was found among men exposed 
to cobalt and diagnosed with hard-metal disease compared to 
those who had not been diagnosed with this disease (d’Adda 
et al. 1994) when measured by radionuclide ventriculogra-
phy and echocardiography. The researchers assumed that 
this finding may have been due to increased diastolic pres-
sure caused by increased wall stiffness and fibrosis due to 
cobalt deposits in the myocardium. In addition, hyperten-
sion and reversible electrocardiographic changes (depressed 
ST segment and T waves) and arrhythmias have been found 
more frequently among persons who have been exposed to 
an average cobalt concentration of 0.01 mg Co/m3 in hard-
metal work than among persons in a reference group (Alex-
andersson and Atterhög 1980, 1983).
In our previous cross-sectional study in a cobalt produc-
tion plant in 1999–2000, there seemed to be an association 
between cumulative cobalt exposure and two echocardio-
graphic parameters, the deceleration time of the velocity 
(DT) of the early rapid filling wave and the left ventricular 
isovolumic relaxation time (IVRT). The results suggested 
that there were changes in the function of the myocardium 
during diastole (Linna et al. 2004). This finding supported 
the hypothesis that cobalt accumulation in the myocardium 
could affect myocardial function.
The aim of this 6-year follow-up was to assess the effects 
of cobalt exposure on functional or structural changes in the 
heart muscles of cobalt-exposed cobalt production workers 
who had been examined by echocardiography in 1999–2000.
Methods
Cobalt process and exposure
The cobalt plant featured in this study is located in Kokkola 
on the west coast of Finland. Between 1966 and 1987, cobalt 
powder was produced from pyrite ore concentrate. Thereaf-
ter, cobalt powder, inorganic cobalt, and nickel compounds 
have been produced using by-products of the metallurgic 
industry as raw material (Linna et al. 2004).
Exposure to most dusts and gases in the process has been 
regularly monitored several times annually since 1966. 
Air samples have been collected by an authorized hygien-
ist both at stationary points and with personal samplers in 
the workers’ breathing zones. Exposure to cobalt has varied 
greatly in range according to the job role even within the 
same department. The range has been 0.02–1.0 mgCo/m3 in 
the sulphatising roasting department, 0.01–0.05 mgCo/m3 in 
the leaching and solution purification department, 0.05–0.25 
mgCo/m3 in the reduction and powder production depart-
ment, and 0.01–0.20 mgCo/m3 in the chemical department 
(Fig. 1) (Linna et al. 2004).
The mean exposure levels to cobalt and its compounds 
were slightly above the current Finnish occupational 
exposure limit (0.05 mg/m3) before 1987, and they have 
been slightly under the limit since the new process was 
initiated (Linna et al. 2004). According to the biologi-
cal monitoring surveillance, exposure to cobalt has been 
the highest in the reduction department. The company’s 
occupational health care unit has measured cobalt uri-
nary concentrations (U-Co); in 1999–2000, levels of 
Fig. 1  Exposure levels (mean) 
by departments (mg/m3)
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U-Co were 11–4107 nmol/l (median 240 nmol/l, N = 29), 
while in 2005–2006, they were 6–6278 nmol/l (median 
230 nmol/L, N = 113).
Cumulative exposure to cobalt, presented as milligram-
years (mg-years), was calculated for each worker using a 
job-exposure matrix based on ambient air measurements 
(Linna et al. 2004). In this study, we completed the infor-
mation on cumulative exposure using the exposure data 
collected during the follow-up period. Between 2000 and 
2006, there were no major changes in the technology or 
processes at the factory, and the exposure levels remained 
stable. In the control group (zinc plant workers), all the 
workers were exposed to zinc, but not to cobalt. For four-
fifth of the zinc workers, the zinc exposure levels were 
0.1–0.2 mg/m3, and for the remaining fifth, the levels were 
around 1 mg/m3.
Design and participants
The employees who participated in this study had already 
been working in the cobalt plant at the end of 1999, and they 
had been exposed to cobalt for at least 1 year (the exposed 
group). The reference group had not been exposed to cobalt. 
In both groups, workers exposed to confounding exposure 
agents, such as lead and arsenic, were excluded. Persons 
with congenital or acquired cardiac valvular disease and 
those with a history of myocardial infarction were excluded 
from the echocardiographic analysis. In this follow-up study, 
we invited all the workers who had been examined by echo-
cardiography in 1999–2000 and whose results were included 
in the analyses. Four employees from the earlier exposed 
group and one from the unexposed group had died; the cause 
of death of one of the exposed workers was heart infarction. 
The deaths of the other deceased workers were not related 
to cardiovascular diseases. Altogether, 19 persons were 
unwilling to participate or could not be contacted. Of the 
previously examined workers exposed to cobalt (n = 109), 
93 (85%) were re-examined, as were 49 (86%) of the 57 who 
had been in the unexposed reference group. The project was 
separate from routine health examinations by the occupa-
tional health services. The workers were examined in 2006 
within a period of 6 months. Participation was voluntary, 
and all participants gave their written informed consent. The 
study plan was approved by the Coordinating Ethics Com-
mittee of the Helsinki University Hospital District.
Questionnaire
Data on working history at the plant after 2000 were 
requested with a self-administered questionnaire. The rea-
sons for changing working tasks, jobs, or workplaces were 
also requested. We inquired about the level of stress, shift 
work, physical exercise, smoking, alcohol consumption, 
symptoms of chest pain or shortness of breath, diseases 
diagnosed by a physician (cardiovascular and pulmonary 
diseases, diabetes), and medication.
Blood pressure measurement 
and electrocardiography
Blood pressure was measured after 10 min of rest in a sitting 
position using an automatic Omron 705CP (Omron Matsu-
saka Co Ltd, Japan), which was tested and validated by the 
importer before and after the study. After two measurements, 
the lower systolic and diastolic pressure and pulse were 
noted. A standard 12-lead electrocardiogram was obtained 
using 12-channel ECG equipment (Marquette Electronics 
Inc., Milwaukee WI, USA) at a paper speed of 50 mm/s. The 
recordings were analysed independently by two experienced 
clinicians, who both coded the recordings without know-
ing their origin (exposed/referent). Coding was performed 
according to the Minnesota 1982 method (Rose et al. 1982).
Laboratory tests
As a random sample, we selected 76 persons from the 
exposed and unexposed groups. Serum gamma-glutamyl 
transferase (S-GT) and carbohydrate-deficient transfer-
rin (S-CDT) levels were analysed. In addition, the serum 
lipid and glucose values of all participants, which had been 
recorded in health examinations during the previous 2 years, 
were also extracted from the files of the factories’ occupa-
tional health centre.
Holter registration
Long-term ECG registration was recorded with Holter 
technics (24-h signal sampling with a three-channel device, 
Braemar Inc., USA). The results were interpreted by a phy-
sician (HL) who is specialized in clinical physiology. Reg-
istrations were started at the beginning of the work shift 
and continued overnight until the next day. The participants 
marked their activities and symptoms during the registration 
period in a diary.
Echocardiography
Echocardiography was performed in the standard fash-
ion using a GE Medical Systems Vivid 7/2006 ultrasound 
device with a 2.5-Mhz transducer and an EchoPac work-
station. Conventional echocardiographic images were 
obtained according to the guidelines of the American Soci-
ety of Echocardiography and the European Association of 
Cardiovascular Imaging (Lang et al. 2005). Echo exams 
were performed by a single operator (MH). Left ventricular 
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mass (LVMASS) was calculated according to the formula 
of Devereux et al. (1986). We performed spectral Doppler 
measurements of blood flow by aligning the interrogating 
beam with the direction of flow according to anatomical 
and colour Doppler information. Mitral flow was obtained 
with the pulsed Doppler sampler (sample volume 4–5 mm 
in length) at the valve tips. Early diastolic filling velocity 
(E), peak atrial filling velocity (A), E/A ratio, E-wave decel-
eration time (DT), and slope were measured from the left 
ventricular filling recordings. We measured the isovolumic 
relaxation time (IVRT) using the technically better pulsed or 
continuous wave recording of the mitral inflow and the left 
ventricular outflow. No angle correction was used. Valvular 
regurgitation was quantified according to the colour Doppler 
information from multiple views. We recorded ventricular 
long-axis motion from the lateral and septal myocardium 
using pulsed-wave tissue Doppler imaging (TDI) in an apical 
four-chamber view with a small sample volume (2–3 mm in 
length) positioned in the myocardium of the basal ventricu-
lar wall, about 1 cm from the mitral annulus. Early diastolic 
myocardial tissue velocity (Em), diastolic myocardial tissue 
velocity after atrial contraction (Am), and their ratio (Em/Am) 
were recorded. Em deceleration time and slope were also 
measured. The E/Em ratio was calculated (Otto 2004). The 
mean of at least three consecutive beats was used. Images 
were stored on videotape on a Sony videocassette recorder 
(SVO-9500MDP), on optic disks in an Echopac Worksta-
tion, and on paper from a thermal printer (UP-890CE). The 
echocardiograms were analysed by a single experienced 
clinician without knowledge of the status of the examined 
persons (exposed/referent). MH performed the measure-
ments, and another cardiologist (VV) checked the results of 
the measurements. The interobserver error was investigated 
from a sample of 30 echocardiograms, and no significant 
differences were observed, the coefficient of the variation 
of echo parameters being 2.3–18.5.
Statistical methods
The normality of the variables was checked, and logarithmic 
transformation was applied if the distribution of the variable 
was skewed. The crude means and standard deviations are 
reported in the tables. The paired t test, the independent sam-
ples t test, and the McNemar test were used in the analysis 
of the differences between the study groups.
An analysis of covariance (ANCOVA) was used to study 
the echocardiograph data. A backward stepwise regression 
analysis was performed on all the echocardiographic param-
eters so that age, exposure, and their interaction were always 
included in the model. Body mass index was included if the 
outcome variable had not been divided by body surface area, 
and heart rate was used if the outcome variable was time 
related. ANCOVA was also used to study the differences 
in the echocardiographic parameters between the various 
designated exposure groups.
In the analyses, high and low exposure was determined 
based on being above or below the median mg-years of 
cobalt exposure (0.47 mg-years in 2000 and 0.55 mg-years 
in 2006). Age was included as a continuous variable in 
the ANCOVA analyses and categorized above and below 
50 years and 56 years in the study in 2000 and in 2006, 
respectively. Independent factors, such as smoking (non-
smoking vs current and ex-smoking), hypertension (as nor-
mal vs elevated (> 140/90) or as diagnosed hypertension), 
and competing athlete status (yes or no), were included in 
the model as dichotomous variables. In some calculations 
(see above), the use of alcohol (weekly consumption over 20 
doses of 12 g of alcohol or SGT > 80), body mass index, and 
heart rate were included in the model as covariates because 
they were considered confounders. The echo values of the 
cross-sectional study in 2006 with the new tissue Doppler 
device were analysed and adjusted for the 2006 confounders. 
Those covariates with significant associations with outcome 
variables remained in the model because they were consid-
ered confounders.
The 95% confidence interval (95% CI) was calculated for 
the differences between two percentages. The level of sig-
nificance in the ANCOVA was set equal to 0.05, but exact 
p values are reported. Computations were carried out using 
SPSS/Win (version 15.0) software.
Results
The characteristics of the examined groups and calculated 
mg-year values are given in Table 1.
There were no significant differences in characteris-
tics between the exposed and unexposed groups in 2006. 
The BMI had increased significantly in the exposed 
group during the follow-up. Both groups seemed to have 
decreased their current smoking level. Alcohol consump-
tion had increased in both groups—significantly in the 
exposed group. The participants in the exposed group 
tended to have increased their leisure-time sport activi-
ties, but not statistically significantly (p = 0.065). On the 
contrary, the participants in the unexposed group had 
decreased their leisure-time sport activities, especially 
the duration and level of strain (data not shown). There 
was no significant difference in reported stress between 
the exposed and unexposed groups (data not shown). In 
the study group, 71% worked shifts, whereas 50% of the 
controls worked shifts.
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Symptoms, diagnosed diseases, and medication
There were no differences between the two study groups 
in relation to symptoms, diagnosed diseases, and medi-
cation in 2006, except for the participants in the exposed 
group more often reporting asthma and other pulmonary 
diseases (Table 2).
For both the exposed group and the unexposed group, 
hypertension was reported more often than 6 years ear-
lier. In both groups, the increase in physician-diagnosed 
hypertension was significant during the follow-up period. 
In the unexposed group, the prevalence of high blood 
pressure had almost doubled. The proportion of persons 
using antihypertensive or other heart medication had 
increased in both groups. The use of beta-blockers was 
more common in the unexposed group.
Subjective complaints of irregular heartbeats (arrhyth-
mia) had increased in the exposed group, but the prev-
alence was at the same level in both groups in 2006 
(Table 2).
Blood pressure, electrocardiographic findings, 
and laboratory tests
There were no differences in measured blood pressure, 
electrocardiographic findings, or laboratory tests between 
Table 1  Characteristics of the exposed and unexposed groups in 2000 and 2006
a Regularly > 0.01 mg Co/m3
Exposed group (n = 93) Unexposed group (n = 49)
2000 2006 2000 2006
Age (year) Mean (SD) 47 (8.3) 53 (8.3) 48 (7.8) 54 (7.8)
Median (range) 50 (28–63) 56 (34–69) 50 (29–61) 56 (35–67)
Body mass index Mean (SD) 26.9 (3.4) 27.7 (3.7) 26.9 (3.2) 27.5 (3.5)
Median (range) 26.5 (21.6–35.0) 27.2 (20.5–37.9) 26.5 (21.6–35.0) 27.1 (21.2–36.9)
Work history (years) Mean (SD) 22.5 (9.9) 28.1 (9.6) 23.8 (8.0) 29.5 (8.0)
Median (range) 25 (2–34) 31 (8–40) 26 (3–25) 32 (7–41)
Exposure time to cobalt (years)a Mean (SD) 20.7 (10.0) 25.7 (9.8) – –
Median (range) 23.0 (0–34) 28.0 (0–39) – –
Exposure to cobalt (mg-years) Mean (SD) 0.56 (0.51) 0.82 (0.79) – –
Median (range) 0.45 (0.06–2.5) 0.55 (0.10–4.1) – –
Smoking status (%) Non-smokers 29% 33% 33% 37%
Ex-smokers or smokers 71% 67% 67% 63%
Consumption of alcohol (drinks/
week)
Mean (SD) 5.0 (4.8) 5.9 (5.6) 6.5 (5.4) 7.1 (6.3)
Median (range) 3.0 (0–20) 4.3 (0–26) 6.0 (0–20) 5.0 (0–25)
Competing athlete status (%) No 91% 85% 79% 88%
Now or earlier 9% 15% 21% 12%
Leisure-time sport activities (%) No, never 5% 3% 4% 8%
Yes, two times a week or less 51% 52% 46% 47%
Yes, at least three times a week 44% 45% 50% 45%
Table 2  Prevalence of reported diseases diagnosed by a physician in 
the exposed and unexposed groups in 2000 and 2006
McNemar test: *p < 0.05; **p < 0.01
Exposed group 
(n = 93)
Unexposed 
group(n = 49)
2000
%
2006
%
2000
%
2006
%
Myocardial infarction 0 1 0 2
Coronary heart disease 2 3 4 4
Heart failure 0 0 0 0
Dilated heart 0 3 2 4
Heart arrhythmias 6 14** 21 16
Cardiomyopathy 0 0 0 0
Any other cardiac disease 1 3 0 0
Hypertension 23 32* 21 37**
Stroke 0 2 0 0
Claudicatio intermittens 1 3 2 2
Bronchial asthma 1 7 0 0
Chronic bronchitis 2 2 2 0
Emphysema 0 0 0 0
Other chronic lung disease 4 7 2 2
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these two study groups in 2006, except that the exposed 
group had higher CDT values (Table 3). The S-CDT mean 
was increased in the exposed group, and the difference 
in the changes between the groups was significant. The 
S-LDL mean had decreased significantly in the unexposed 
group, but, again, the differences between the changes in 
the two groups between 2000 and 2006 were not signifi-
cant (Table 3).
Both systolic and diastolic blood pressure had risen in 
the exposed group in 2006 when the levels were compared 
to the results from 2000 (p < 0.05 and p < 0.001, respec-
tively), but the differences in the changes in 2000–2006 
between the two groups were not significant (Table 3).
There were no significant differences in the changes in 
the ECG findings in 2000–2006 between the two groups 
(Table 4).
Table 3  Blood pressure, heart rate, and laboratory test results in the exposed and unexposed groups in 2000 and 2006
Paired t test: *p < 0.05; **p < 0.01; ***p < 0.001
Exposed group (n = 93) Unexposed group (n = 49) t test between the 
group differences
2000 2006 Difference 2000 2006 Difference p value
Systolic blood pressure, mmHg Mean 135.2 142*** 6.8 138.3 140.8 2.5 0.159
SD 15.5 15.0 16.4 14.9 17.1 17.5
Diastolic blood pressure, mmHg Mean 87.7 90.1* 2.3 89.2 89.3 0.02 0.217
SD 9.7 8.4 9.9 10.4 9.5 11.2
Serum gamma-glutamyl transferase, S-GT (U/l) Mean 50.4 52.8 2.40 35.5 41.7 6.2 0.482
SD 56.4 47.6 29.9 15.5 31.7 27.7
Serum carbohydrate-deficient transferrin, S-CDT (U/l) Mean 1.5 1.6 0.09 1.6 1.3 − 0.30 0.048
SD 0.3 0.5 0.4 0.49 0.79 0.9
Serum glucose (mmol/l) Mean 5.4 5.5 0.09 5.7 5.5 − 0.17 0.251
SD 0.7 0.5 0.93 1.1 0.7 1.4
Serum total cholesterol (mmol/l) Mean 5.5 5.4 − 0.08 5.7 5.4 − 0.33 0.383
SD 1.2 1.1 1.7 1.0 0.8 1.3
Serum HDL cholesterol (mmol/l) Mean 1.3 1.4 0.10 1.3 1.3 0.00 0.353
SD 0.3 0.4 0.6 0.4 0.4 0.5
Serum triglycerides (mmol/l) Mean 1.6 1.6 − 0.01 1.6 1.8 0.11 0.661
SD 0.9 0.8 1.2 1.1 1.7 2.1
Serum LDL cholesterol (mmol/l) Mean 3.6 3.4 − 0.24 3.6 3.3* -0.38 0.578
SD 1.0 0.9 1.4 0.9 0.7 1.1
Table 4  Electrocardiographic 
(ECG) conduction parameters 
for the exposed and unexposed 
groups in 2000 and 2006
# 2006 values PQ time
Paired t test:*p < 0.05; **p < 0.01; ***p < 0.001
Exposed (n = 93) Unexposed (n = 49) t test
2000 2006 Difference 2000 2006 Difference p value
PR time, ms # Mean 164.4 166.4 167.9 169.8
SD 24.5 23.6 25.8 24.3
QRS time, ms Mean 97.1 96.3 − 0.8 99.4 96.7 − 2.8 0.296
SD 10.3 11.9 10.6 8.8 13.3 10.6
QTc time, ms Mean 408.3 408.7 0.4 410.8 410.0 -0.8 0.762
SD 20.3 18.5 22.1 16.8 15.7 20.1
QT time, ms Mean 417.7 399.3*** − 18.4 416.1 414.7 − 1.5 0.062
SD 37.8 33.4 43.6 64.0 35.2 62.0
Pulse/min Mean 59.1 63.9*** 4.8 58.0 60.3 2.3 0.173
SD 8.2 10.5 10.3 9.6 10.7 9.9
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Holter registration
Holter results were obtained only from the examinations 
in 2006. Abnormal results in the 24-h ECG registration 
appeared in 10.4% of the exposed and 9.7% of the unexposed 
groups. The exposed group had more ventricular extrasys-
tolic (VES) beats than the unexposed group (mean 209 (SD 
1098) vs 114 (SD 362), respectively), and the unexposed 
group had more atrial extrasystolic beats (AES) than the 
exposed group (mean 216 (SD 1296) vs 87 (SD 392), respec-
tively). Only one case of severe arrhythmia was found, and it 
had already been recognized in one of the referents.
Echocardiography
One person with a history and echocardiographic signs of 
myocardial infarction was excluded from echocardiographic 
analysis in both groups. No signs of cardiomyopathy or car-
diac failure/insufficiency were found clinically at the indi-
vidual level.
The echocardiographic results for 2006 are presented in 
Table 5. Using the ANCOVA models, we considered the 
difference in the echo variables between the exposed and 
unexposed groups in 2006. In this analysis, the values of 
the echo parameters were adjusted to the other variables in 
2006. There were no differences in any parameter measuring 
heart volumes, wall thickness, or muscle mass between the 
exposed and unexposed groups in 2006. Only  Am tissue was 
smaller in the unexposed group. There were no differences 
either in the DT and IVRT values between the study groups. 
There were no differences in any of the echocardiographic 
parameters in 2000 between those who participated in 2006 
and those who did not (data not shown).
Discussion
This study is the first follow-up cohort study to assess the 
effects of occupational cobalt exposure on the cardiovascular 
system. We carried out a 6-year follow-up with echocardi-
ography in a cobalt production plant. Cobalt exposure was 
not associated with detrimental effects on the function or 
structure of the heart muscle, and it did not seem to have 
caused damage to the cardiovascular system.
We performed a cross-sectional study in 2000 (Linna 
et al. 2004) and repeated it in 2006 for those who had been 
examined with echocardiography in 2000. There are several 
strengths to our study. All the participants were re-exam-
ined by the same investigator (a cardiologist). Our study 
was based on a large, occupationally exposed study popula-
tion, and we could take the advantage of a reliable modern 
method, namely echocardiography with a tissue Doppler. 
Participation rate is high (85% and 86% in the exposed 
and unexposed groups, respectively). Another strength of 
the study was the exposure assessment, which was based 
on regular industrial hygienic measurement over decades. 
The weaknesses of the study include the limited number of 
participants in the unexposed group, which diminished the 
power of the study, and the subjective nature of the health 
data from the questionnaire. On the other hand, we decided 
to use the results of the laboratory tests as background vari-
ables to assess the possible changes in the lifestyle profiles 
of the groups in the follow-up. These test results were in 
concordance with the questionnaire results.
We have no accurate personal health information on those 
who did not participate in the follow-up. According to the 
information from the occupational health centre, no clinical 
cases of cardiomyopathy were found in this factory during 
the follow-up period. Occupational asthma has been associ-
ated with cobalt exposure, and we have published a case 
series on cobalt-induced asthma previously (Sauni et al. 
2010). However, there is no evidence that occupational 
asthma is associated with a risk of heart failure. We could 
not see differences in any of the echocardiographic param-
eters in 2000 between those who participated in 2006 and 
those who did not. Thus, there does not seem to be a remark-
able selection bias.
Echocardiography with a tissue Doppler was used in 
2006, because we wanted to confirm previous findings with 
reliable, modern, and high-quality technology. Therefore, the 
results of the echo method with the tissue Doppler were not 
comparable with the previous Doppler echocardiography. 
The results in 2006 have, therefore, been analysed as a new 
cross-sectional study design using similar statistical models 
as employed in 2000.
Exposure levels of cobalt and other impurities in the air 
have been monitored regularly in the cobalt factory featured 
in our study, and this enabled individual assessment of the 
cumulative exposure to cobalt (Linna et al. 2004). The work-
ing environment in this study design offered no exposure 
to agents other than cobalt that would have had harmful 
effects on the cardiovascular system. Exposure to zinc does 
not cause effects on the heart muscle, and the group exposed 
to zinc was an epidemiologically ideal reference group, 
because it came from a factory in the same industrial area 
with the same recruitment criteria and similar pre-employ-
ment examination by the same occupational health unit.
These results should be applied and generalized to the 
exposure levels monitored in this factory. The mean expo-
sure levels of cobalt and its compounds in the plant were 
slightly over the current Finnish occupational exposure limit 
(0.05 mg/m3) before 1987, but they have been slightly under 
the limit since the new process was initiated. During the 
early years of cobalt production, the cobalt levels may have 
been considerably higher (i.e. over 1 mg/m3), especially in 
the roasting department. Finnish occupational limits have 
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often been exceeded also in the reduction and powder pro-
duction departments. In the 2000s, the concentrations of 
cobalt in ambient air tended to decrease. The follow-up in 
biomonitoring U-Co showed that exposure remained at the 
same level.
A search of the literature found one Belgian epidemio-
logic cross-sectional study that did not find an association 
between cobalt exposure and incipient signs of cardiomyo-
pathy (Lantin et al. 2013). The researchers studied 256 male 
refinery workers with electro- and echocardiography. Their 
results were adjusted to an exposure index reflecting long-
term exposure to cobalt. No dose–response relationship was 
found between exposure to cobalt and parameters reflect-
ing possible dilated cardiomyopathy in their exposed study 
population.
In our cross-sectional study in 2000, we found that higher 
cobalt exposure was associated with altered left ventricu-
lar diastolic function as measured by echocardiography 
(Linna et al. 2004) The isovolumic relaxation time (IVRT) 
was prolonged in the highly exposed group when compared 
with that of the less exposed and reference groups, and a 
prolonged deceleration time (DT) was observed among the 
exposed persons. These findings were in concordance with 
those of D’Adda et al. (1994), who reported that an accumu-
lation of cobalt in the myocardium might result in increased 
myocardial stiffness. Contrary to the previous echo findings, 
in 2006, we found that DT and IVRT were similar in the 
exposed and unexposed groups. In the 2006 results, the use 
of the tissue Doppler, when adjusted for confounding vari-
ables, did not show any differences between the exposed and 
unexposed groups. Only the  Am tissue was smaller in the 
unexposed group; however, the higher age and heart rate 
(time-related variables) best explained these values. Fur-
thermore, no significant differences were found between the 
exposed and unexposed workers in the laboratory values, 
ECG parameters—including heart rate—or Holter registra-
tion. These findings support the no-effect results of cobalt 
exposure found by the echocardiography.
The differences in the echo parameters between the study 
groups in 2000 were minimal when compared with the path-
ological findings in the context of clinical practice. Small 
changes in echo parameters are apt to become significant in 
group-level comparisons in epidemiological studies.
When there was no progression of the earlier changes 
in the exposed group compared to unexposed group, we 
consider the earlier findings from 2000 in the exposed 
group to have developed randomly; while these findings 
were statistically significant, they were not clinically sig-
nificant. The changes in the echocardiographic parameters 
may have been associated with the process of ageing and 
its physiological changes on the cardiovascular system, 
which may explain many of our findings in these two 
cross-sectional studies with a 6-year interval.
In the questionnaire data, background factors—such as 
lifestyle habits—had changed in both groups during the 
follow-up. The BMI had increased in both groups, and the 
use of alcohol was more common among the unexposed 
participants. The exposed participants had increased their 
leisure-time sport activities, while unexposed participants 
had decreased such activities. It seemed that the lifestyle 
habits of the unexposed group tended to have changed more 
in an unhealthy direction compared to the exposed group. In 
this middle-aged male population, possibly the largest effect 
on heart function was due to hypertension and its medica-
tion. This explanation is supported by the more frequent 
reports of physician-diagnosed hypertension in both groups, 
which was present even more frequently in the unexposed 
group. The unexposed group used more beta-blockers as 
antihypertensive medication compared to the exposed group 
(18% vs 11%). Many of the echo variables are dependent on 
hypertension and heart rate and, therefore, we adjusted the 
variables to both factors in the analysis.
It is possible that our previous findings of a possible 
increased stiffness of the myocardium were not associated 
with cobalt exposure. It seems likely that even if cobalt 
exposure has a small effect on heart function, it is unlikely 
that this effect can be demonstrated in a middle-aged male 
population with many changing risk factors for cardiovas-
cular diseases and medication affecting heart function. The 
exposed and unexposed groups did not differ from each 
other clinically or statistically significantly with respect to 
any echo variable, meaning we could not conclude there 
were detrimental effects on the heart due to exposure to 
cobalt. Based on the findings of this study, there is no 
need to add heart-specific tests to the health surveillance 
scheme of the cobalt-exposed workers when exposure lev-
els do not exceed those reported in this study.
Conclusions
We found no cardiac dysfunction that could be attributed to 
cobalt exposure. If there are effects of cobalt exposure on the 
functions of the heart muscle, they are probably smaller than 
the effects of ageing, medication, and traditional cardiovas-
cular risk factors, such as elevated blood pressure.
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